Open Innovation Drug Discovery

Participant Awards

The pharmaceutical drug discovery process is long and iterative and involves multiple learning cycles. Thus, we are honored that OIDD participants have chosen to partner with Lilly in our quest to advance science and discover the medicines of tomorrow. At the end of each year, we recognize those investigators who have distinguished themselves for outstanding levels of participation in the OIDD program.

Outstanding OIDD Collaborator

This award is given to those OIDD investigators who have entered a collaboration agreement with Lilly through the OIDD program. Read More >

Outstanding Continuous Contribution to Drug Discovery

This award is given to the OIDD investigators who have made both significant and continuous contributions to the OIDD program, either through submitting the highest number of compounds for biological screening, or through accessing our privileged compound libraries to test multiple biological hypotheses over sequential years. Read More >

Outstanding Contribution to Drug Discovery

This award is given to OIDD investigators who have made significant contributions to the OIDD program, either through submitting the highest number of compounds for biological screening, or through accessing our privileged compound libraries to test their biological hypotheses. Read More >